Completed
Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)
NCT00945139
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- University of New Mexico Albuquerque, New Mexico, United States
- New Mexico Cancer Care Associates Santa Fe, New Mexico, United States
- New York University Cancer Institute New York, United States